139 related articles for article (PubMed ID: 15355938)
1. Pseudomonas aeruginosa-induced infection and degradation of human wound fluid and skin proteins ex vivo are eradicated by a synthetic cationic polymer.
Werthén M; Davoudi M; Sonesson A; Nitsche DP; Mörgelin M; Blom K; Schmidtchen A
J Antimicrob Chemother; 2004 Oct; 54(4):772-9. PubMed ID: 15355938
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial efficacy and toxicity of novel CAMPs against P. aeruginosa infection in a murine skin wound infection model.
Yang M; Zhang C; Hansen SA; Mitchell WJ; Zhang MZ; Zhang S
BMC Microbiol; 2019 Dec; 19(1):293. PubMed ID: 31842727
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of a pig-derived peptide antibiotic on porcine wound infections.
Ceccarelli AV; Cole AM; Park AK; Tahk S; Yoshioka D; Ganz T
Comp Med; 2001 Feb; 51(1):75-9. PubMed ID: 11926306
[TBL] [Abstract][Full Text] [Related]
4. Tryptophan end-tagging of antimicrobial peptides for increased potency against Pseudomonas aeruginosa.
Pasupuleti M; Chalupka A; Mörgelin M; Schmidtchen A; Malmsten M
Biochim Biophys Acta; 2009 Aug; 1790(8):800-8. PubMed ID: 19345721
[TBL] [Abstract][Full Text] [Related]
5. Highly selective end-tagged antimicrobial peptides derived from PRELP.
Malmsten M; Kasetty G; Pasupuleti M; Alenfall J; Schmidtchen A
PLoS One; 2011 Jan; 6(1):e16400. PubMed ID: 21298015
[TBL] [Abstract][Full Text] [Related]
6. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37.
Schmidtchen A; Frick IM; Andersson E; Tapper H; Björck L
Mol Microbiol; 2002 Oct; 46(1):157-68. PubMed ID: 12366839
[TBL] [Abstract][Full Text] [Related]
7. Impact of a novel, antimicrobial dressing on in vivo, Pseudomonas aeruginosa wound biofilm: quantitative comparative analysis using a rabbit ear model.
Seth AK; Zhong A; Nguyen KT; Hong SJ; Leung KP; Galiano RD; Mustoe TA
Wound Repair Regen; 2014; 22(6):712-9. PubMed ID: 25230854
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of chlorhexidine, polihexanide and tissue-tolerable plasma against Pseudomonas aeruginosa biofilms grown on polystyrene and silicone materials.
Hübner NO; Matthes R; Koban I; Rändler C; Müller G; Bender C; Kindel E; Kocher T; Kramer A
Skin Pharmacol Physiol; 2010; 23 Suppl():28-34. PubMed ID: 20829659
[TBL] [Abstract][Full Text] [Related]
9. Activity of histone H1.2 in infected burn wounds.
Jacobsen F; Baraniskin A; Mertens J; Mittler D; Mohammadi-Tabrisi A; Schubert S; Soltau M; Lehnhardt M; Behnke B; Gatermann S; Steinau HU; Steinstraesser L
J Antimicrob Chemother; 2005 May; 55(5):735-41. PubMed ID: 15772144
[TBL] [Abstract][Full Text] [Related]
10. Novel models for bacterial colonization and infection of full-thickness wounds in rats.
Asada M; Nakagami G; Minematsu T; Nagase T; Akase T; Huang L; Yoshimura K; Sanada H
Wound Repair Regen; 2012; 20(4):601-10. PubMed ID: 22642411
[TBL] [Abstract][Full Text] [Related]
11. A novel titanium wound chamber for the study of wound infections in pigs.
Steinstraesser L; Vranckx JJ; Mohammadi-Tabrisi A; Jacobsen F; Mittler D; Lehnhardt M; Langer S; Kuhnen C; Gatermann S; Steinau HU; Eriksson E
Comp Med; 2006 Aug; 56(4):279-85. PubMed ID: 16941955
[TBL] [Abstract][Full Text] [Related]
12. The effect of negative pressure wound therapy with periodic instillation using antimicrobial solutions on Pseudomonas aeruginosa biofilm on porcine skin explants.
Phillips PL; Yang Q; Schultz GS
Int Wound J; 2013 Dec; 10 Suppl 1(Suppl 1):48-55. PubMed ID: 24251844
[TBL] [Abstract][Full Text] [Related]
13. Skin-Derived C-Terminal Filaggrin-2 Fragments Are Pseudomonas aeruginosa-Directed Antimicrobials Targeting Bacterial Replication.
Hansmann B; Schröder JM; Gerstel U
PLoS Pathog; 2015 Sep; 11(9):e1005159. PubMed ID: 26371476
[TBL] [Abstract][Full Text] [Related]
14. [A mixture of antimicrobial peptides and fibrin glue in treatment of partial-thickness burn wounds].
Lahoda LU; Wang SC; Vogt PM
Chirurg; 2006 Mar; 77(3):251-6. PubMed ID: 16208508
[TBL] [Abstract][Full Text] [Related]
15. Short Synthetic β-Sheet Antimicrobial Peptides for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Burn Wound Infections.
Zhong G; Cheng J; Liang ZC; Xu L; Lou W; Bao C; Ong ZY; Dong H; Yang YY; Fan W
Adv Healthc Mater; 2017 Apr; 6(7):. PubMed ID: 28135045
[TBL] [Abstract][Full Text] [Related]
16. Elastase-producing Pseudomonas aeruginosa degrade plasma proteins and extracellular products of human skin and fibroblasts, and inhibit fibroblast growth.
Schmidtchen A; Holst E; Tapper H; Björck L
Microb Pathog; 2003 Jan; 34(1):47-55. PubMed ID: 12620384
[TBL] [Abstract][Full Text] [Related]
17. Nitrosoglutathione generating nitric oxide nanoparticles as an improved strategy for combating Pseudomonas aeruginosa-infected wounds.
Chouake J; Schairer D; Kutner A; Sanchez DA; Makdisi J; Blecher-Paz K; Nacharaju P; Tuckman-Vernon C; Gialanella P; Friedman JM; Nosanchuk JD; Friedman AJ
J Drugs Dermatol; 2012 Dec; 11(12):1471-7. PubMed ID: 23377518
[TBL] [Abstract][Full Text] [Related]
18. Aerosol treatment with MNEI suppresses bacterial proliferation in a model of chronic Pseudomonas aeruginosa lung infection.
Woods DE; Cantin A; Cooley J; Kenney DM; Remold-O'Donnell E
Pediatr Pulmonol; 2005 Feb; 39(2):141-9. PubMed ID: 15633200
[TBL] [Abstract][Full Text] [Related]
19. Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications.
Deslouches B; Islam K; Craigo JK; Paranjape SM; Montelaro RC; Mietzner TA
Antimicrob Agents Chemother; 2005 Aug; 49(8):3208-16. PubMed ID: 16048927
[TBL] [Abstract][Full Text] [Related]
20. Development, standardization and testing of a bacterial wound infection model based on ex vivo human skin.
Schaudinn C; Dittmann C; Jurisch J; Laue M; Günday-Türeli N; Blume-Peytavi U; Vogt A; Rancan F
PLoS One; 2017; 12(11):e0186946. PubMed ID: 29140982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
